Ex parte SONTHEIMER et al. - Page 2




          Appeal No. 1995-2785                                                          
          Application No. 07/576,423                                                    


          29, which are the only other claims remaining in the                          
          application, stand "objected to as being dependent upon a                     
          rejected base claim, but would be allowable if rewritten in                   
          independent form."  See the Second Supplemental Examiner's                    
          Answer (Paper No. 31), page 1.                                                


                                 REPRESENTATIVE CLAIMS                                  
               Claims 17, 21, and 26, which are illustrative of the                     
          subject matter on appeal, read as follows:                                    
               17.  A purified nucleic acid segment that corresponds to,                
          or is complementary to, from a 14 to 1890 nucleotide long                     
          region of the DNA sequence of Figure 2 of the drawings, said                  
          segment being capable of forming a hybrid with the nucleotide                 
          sequence of Figure 2 under conditions that include 6 x SSC at                 
          42EC.                                                                         
               21.  A method for identifying the presence of a nucleic                  
          acid molecule having a sequence in accordance with claim 17 in                
          a biological sample suspected of containing such a molecule,                  
          the method comprising the steps of:                                           
               (a) incubating nucleic acids from the biological sample                  
                    with a DNA segment as defined by any one of claims                  
                    17 through 19 under conditions appropriate for the                  
                    formation of specific hybrids; and                                  
               (b) detecting the formation of specific hybrids between                  
                    the nucleic acids and the segment by means of a                     
                    detectable label, the formation of such hybrids                     
                    being indicative of the presence of such a nucleic                  
                    acid sequence in the biological sample.                             


                                          -2-                                           




Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next 

Last modified: November 3, 2007